Biostar Pharmaceuticals, Inc. (BSPM)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 25, 2026
0.00%
Market Cap 3.00
Revenue (ttm) 317.79K
Net Income (ttm) 934.35K
Shares Out 2.64M
EPS (ttm) 0.34
PE Ratio 0.00
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 100
Average Volume 6,530
Open 0.0000
Previous Close n/a
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0500
Beta -4,884.85
RSI 47.37
Earnings Date n/a

About Biostar Pharmaceuticals

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associ... [Read more]

Sector Healthcare
Founded 2007
Employees 200
Stock Exchange OTCMKTS
Ticker Symbol BSPM
Full Company Profile

Financial Performance

In 2016, Biostar Pharmaceuticals's revenue was $2.38 million, a decrease of -91.21% compared to the previous year's $27.13 million. Losses were -$5.70 million, -77.31% less than in 2015.

Financial Statements

News

There is no news available yet.